The technique of immunocytochemistry was used to identify myoglobin in kidney, confirming a diagnosis of neuroleptic malignant syndrome following an otherwise obscure autopsy in a decomposed body. The features of neuroleptic malignant syndrome are reviewed with a differential diagnosis of myoglobin renal casts. The report emphasizes a thorough and detailed assessment of deaths which occur during treatment with neuroleptic drugs.
Get full access to this article
View all access options for this article.
References
1.
BristowM. F.KohenD. (1993) How ‘malignant’ is the Neuroleptic Malignant Syndrome?BMJ307, 1223–4.
2.
DolanM.BoydC.ShettyG. (1995) Neuroleptic induced sudden death — a case report and critical review. Med. Sci. Law35, 169–74.
3.
ForrestA. R.GallowayJ. H.MarshI. D.StrachanG. I.ClarkeJ. C. (1994) A fatal overdose of 3–4, methylenedioxyamphetamine derivative. For. Sci. Int.64, 57–9.
4.
JasaniBSchmidK. W. (1993) Immunocytochemistry in Diagnostic Histopathology. Edinburgh, Churchill Livingston.
5.
KeckP. E.McElroyS. L.PopeH. G. (1991) Neuroleptic malignant syndrome. Current Opinion in Psychiat.4, 34–7.
6.
KnightB. (1991) Forensic Pathology. London, Edward Arnold.
7.
PrescottJ. R.RobertsS. P.WilliamsG. (1992) Malignant hyperpyrexia: a rare case of post operative death. J. Clin. Path.45, 361–3.
8.
ShalevA.HermeshH.MunitzH. (1989) Mortality of neuroleptic malignant syndrome. J. Clin. Psych.50, 18–25.
